Customize your JAMA Network experience by selecting one or more topics from the list below.
Atrial fibrillation (AF) affects more than 33 million people worldwide.1 The prevalence in high-income countries is 1% to 4% but increases to more than 13% of persons older than 80 years of age.2 Although embolic stroke is the most feared complication, over the past few decades, AF has been associated with increased risks of myocardial infarction,3 heart failure,4 dementia,5 chronic kidney disease,6,7 venous thromboembolism,8 and mortality.9 Conversely, biologically plausible bidirectional relations have been reported, such that myocardial infarction,10 heart failure,10 chronic kidney disease,6,7 and venous thromboembolism11 are associated with increased risk of incident AF.
Rahman F, Ko D, Benjamin EJ. Association of Atrial Fibrillation and Cancer. JAMA Cardiol. 2016;1(4):384–386. doi:10.1001/jamacardio.2016.0582
Create a personal account or sign in to: